Bold Prediction: NuScale Power Is About to Soar. Here's Why.

NuScale is highlighted as the only U.S. nuclear reactor developer with an NRC-approved small modular reactor design, positioning it to benefit from AI-driven power demand and the clean-energy transition. However, commercial revenue is still essentially nil and the stock remains about 75% below its all-time high, so the upside case is largely based on regulatory advantage and long-term execution. The article cites an average analyst price target of about $17, implying nearly 30% upside from current levels.

Analysis

The market is still pricing SMR like a pre-revenue story, but the more important second-order effect is option value on licensing credibility. In a capital-intensive technology where customers are making multi-year power procurement decisions, regulatory de-risking can matter more than near-term revenue, because it compresses the time to first contract and improves financing terms. That said, the stock’s move is vulnerable to the classic “good science, bad calendar” problem: if commercial awards slip even 12-18 months, equity dilution and stranded SG&A become the dominant narrative again.

The relative winner from a broader theme perspective may be the incumbents and adjacent suppliers, not the pure-play developer. Utilities, EPC contractors, fuel-cycle/service providers, and grid equipment names can monetize nuclear optimism earlier than SMR builders because they get paid during site prep, interconnect, and permitting, not after reactor ramp. Conversely, OKLO remains the cleaner hedge against SMR-specific valuation compression: if the market decides to re-rate on execution probability rather than design approval, the names with less regulatory distance to commercialization can outperform on a sequencing basis.

For AI-linked power demand, the hidden issue is not generation capacity alone but load-following and baseload reliability. If large buyers start treating nuclear as a strategic procurement category, that could improve long-dated offtake visibility and support higher valuation multiples across the nuclear complex; if not, the trade will revert to a speculative duration asset with high financing sensitivity. Consensus is likely underestimating how quickly sentiment can turn if there is no signed utility/industrial PPA catalyst in the next 1-2 quarters.

Near term, the upside is best expressed through defined-risk structures rather than outright equity, because the gap between headline optimism and operating reality is still wide. The best risk/reward is to own the theme but fade the most crowded expression if the stock outpaces any fundamental milestones.

Key Decisions for Investors

• Buy SMR Jan-2027 call spreads instead of common: participate in a multi-year re-rating while capping downside if commercialization slips; only add on pullbacks tied to financing/dilution fears rather than momentum spikes.
• Pair long SMR / short OKLO tactically for 3-6 months only if the thesis is regulatory credibility over execution pace; reverse the pair if OKLO secures a near-term commercial milestone first.
• If seeking cleaner AI-power exposure, rotate part of the basket into utility or grid-enablement names rather than pure SMR developers; these monetize the theme sooner and have lower binary risk.
• Trim SMR into strength if no contract backlog emerges within the next 1-2 quarters; the main failure mode is valuation outrunning order visibility, which can compress 20-30% quickly on any capital raise.
• For higher-conviction thematic exposure, use small-sized long volatility in SMR around catalyst dates (regulatory, partnership, financing announcements) because the stock should gap on news, but the downside on silence is equally sharp.